KRAS mutation was detected in 154 (67 %) of 229 patients with IPMN arising in the pancreatic head and 97 (75 %) of 130 patients in the body or tail. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.